134 related articles for article (PubMed ID: 22896753)
1. The journey from autologous typing to SEREX, NY-ESO-1, and cancer/testis antigens.
Chen YT
Cancer Immun; 2012; 12():8. PubMed ID: 22896753
[No Abstract] [Full Text] [Related]
2. The genealogy of SEREX.
Pfreundschuh M
Cancer Immun; 2012; 12():7. PubMed ID: 22896752
[No Abstract] [Full Text] [Related]
3. The discovery of cancer/testis antigens by autologous typing with T cell clones and the evolution of cancer vaccines.
Jäger E; Knuth A
Cancer Immun; 2012; 12():6. PubMed ID: 22896751
[No Abstract] [Full Text] [Related]
4. Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes.
Jäger E; Chen YT; Drijfhout JW; Karbach J; Ringhoffer M; Jäger D; Arand M; Wada H; Noguchi Y; Stockert E; Old LJ; Knuth A
J Exp Med; 1998 Jan; 187(2):265-70. PubMed ID: 9432985
[TBL] [Abstract][Full Text] [Related]
5. Naturally occurring human lymphocyte antigen-A2 restricted CD8+ T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients.
Valmori D; Dutoit V; Liénard D; Rimoldi D; Pittet MJ; Champagne P; Ellefsen K; Sahin U; Speiser D; Lejeune F; Cerottini JC; Romero P
Cancer Res; 2000 Aug; 60(16):4499-506. PubMed ID: 10969798
[TBL] [Abstract][Full Text] [Related]
6. A survey of the humoral immune response of cancer patients to a panel of human tumor antigens.
Stockert E; Jäger E; Chen YT; Scanlan MJ; Gout I; Karbach J; Arand M; Knuth A; Old LJ
J Exp Med; 1998 Apr; 187(8):1349-54. PubMed ID: 9547346
[TBL] [Abstract][Full Text] [Related]
7. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening.
Chen YT; Scanlan MJ; Sahin U; Türeci O; Gure AO; Tsang S; Williamson B; Stockert E; Pfreundschuh M; Old LJ
Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1914-8. PubMed ID: 9050879
[TBL] [Abstract][Full Text] [Related]
8. Fine-mapping naturally occurring NY-ESO-1 antibody epitopes in melanoma patients' sera using short overlapping peptides and full-length recombinant protein.
Komatsu N; Jackson HM; Chan KF; Oveissi S; Cebon J; Itoh K; Chen W
Mol Immunol; 2013 Jul; 54(3-4):465-71. PubMed ID: 23454162
[TBL] [Abstract][Full Text] [Related]
9. Serological cloning of cancer/testis antigens expressed in prostate cancer using cDNA phage surface display.
Fosså A; Alsøe L; Crameri R; Funderud S; Gaudernack G; Smeland EB
Cancer Immunol Immunother; 2004 May; 53(5):431-8. PubMed ID: 14747957
[TBL] [Abstract][Full Text] [Related]
10. HLA-DP4 expression and immunity to NY-ESO-1: correlation and characterization of cytotoxic CD4+ CD25- CD8- T cell clones.
Huarte E; Karbach J; Gnjatic S; Bender A; Jäger D; Arand M; Atanackovic D; Skipper J; Ritter G; Chen YT; Old LJ; Knuth A; Jäger E
Cancer Immun; 2004 Dec; 4():15. PubMed ID: 15600300
[TBL] [Abstract][Full Text] [Related]
11. Fucoidin enhances dendritic cell-mediated T-cell cytotoxicity against NY-ESO-1 expressing human cancer cells.
Hu Y; Cheng SC; Chan KT; Ke Y; Xue B; Sin FW; Zeng C; Xie Y
Biochem Biophys Res Commun; 2010 Feb; 392(3):329-34. PubMed ID: 20067767
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the B-cell repertoire against antigens expressed by human neoplasms.
Preuss KD; Zwick C; Bormann C; Neumann F; Pfreundschuh M
Immunol Rev; 2002 Oct; 188():43-50. PubMed ID: 12445280
[TBL] [Abstract][Full Text] [Related]
13. Exploitation of the B cell repertoire for the identification of human tumor antigens.
Pfreundschuh M
Cancer Chemother Pharmacol; 2000; 46 Suppl():S3-7. PubMed ID: 10950139
[TBL] [Abstract][Full Text] [Related]
14. Serological identification of immunogenic antigens in acute monocytic leukemia.
Chen G; Zhang W; Cao X; Li F; Liu X; Yao L
Leuk Res; 2005 May; 29(5):503-9. PubMed ID: 15755502
[TBL] [Abstract][Full Text] [Related]
15. A novel human-derived antibody against NY-ESO-1 improves the efficacy of chemotherapy.
Gupta A; Nuber N; Esslinger C; Wittenbrink M; Treder M; Landshammer A; Noguchi T; Kelly M; Gnjatic S; Ritter E; von Boehmer L; Nishikawa H; Shiku H; Old L; Ritter G; Knuth A; van den Broek M
Cancer Immun; 2013; 13():3. PubMed ID: 23390374
[TBL] [Abstract][Full Text] [Related]
16. Polymeric structure and host Toll-like receptor 4 dictate immunogenicity of NY-ESO-1 antigen in vivo.
Liu Y; Tian X; Leitner WW; Aldridge ME; Zheng J; Yu Z; Restifo NP; Weiss R; Scheiblhofer S; Xie C; Sun R; Cheng G; Zeng G
J Biol Chem; 2011 Oct; 286(43):37077-84. PubMed ID: 21900253
[TBL] [Abstract][Full Text] [Related]
17. Heteroclitic serological response in esophageal and prostate cancer patients after NY-ESO-1 protein vaccination.
Kawada J; Wada H; Isobe M; Gnjatic S; Nishikawa H; Jungbluth AA; Okazaki N; Uenaka A; Nakamura Y; Fujiwara S; Mizuno N; Saika T; Ritter E; Yamasaki M; Miyata H; Ritter G; Murphy R; Venhaus R; Pan L; Old LJ; Doki Y; Nakayama E
Int J Cancer; 2012 Feb; 130(3):584-92. PubMed ID: 21413013
[TBL] [Abstract][Full Text] [Related]
18. In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines.
Nishikawa H; Sato E; Briones G; Chen LM; Matsuo M; Nagata Y; Ritter G; Jäger E; Nomura H; Kondo S; Tawara I; Kato T; Shiku H; Old LJ; Galán JE; Gnjatic S
J Clin Invest; 2006 Jul; 116(7):1946-54. PubMed ID: 16794737
[TBL] [Abstract][Full Text] [Related]
19. Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue gene.
Jäger D; Stockert E; Scanlan MJ; Güre AO; Jäger E; Knuth A; Old LJ; Chen YT
Cancer Res; 1999 Dec; 59(24):6197-204. PubMed ID: 10626813
[TBL] [Abstract][Full Text] [Related]
20. NY-ESO-1 expression and immunogenicity in malignant and benign breast tumors.
Sugita Y; Wada H; Fujita S; Nakata T; Sato S; Noguchi Y; Jungbluth AA; Yamaguchi M; Chen YT; Stockert E; Gnjatic S; Williamson B; Scanlan MJ; Ono T; Sakita I; Yasui M; Miyoshi Y; Tamaki Y; Matsuura N; Noguchi S; Old LJ; Nakayama E; Monden M
Cancer Res; 2004 Mar; 64(6):2199-204. PubMed ID: 15026363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]